Gene · 7399
Papers2,630
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 2,630
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CAMSAP1 Mutation Correlates With Improved Prognosis in Small Cell Lung Cancer Patients Treated With Platinum-Based Chemotherapy. | Front Cell Dev Biol | 2021 | 35087829 | PubTator, text mining | PubMed |
| Immune Landscape Refines the Classification of Colorectal Cancer With Heterogeneous Prognosis, Tumor Microenvironment and Distinct Sensitivity to Frontline Therapies. | Front Cell Dev Biol | 2021 | 35083217 | PubTator, text mining | PubMed |
| Gene-Based Therapeutics for Inherited Retinal Diseases. | Front Genet | 2021 | 35069693 | PubTator, text mining | PubMed |
| Co-Mutation of FAT3 and LRP1B in Lung Adenocarcinoma Defines a Unique Subset Correlated With the Efficacy of Immunotherapy. | Front Immunol | 2021 | 35069585 | PubTator, text mining | PubMed |
| There Is More Than Meets the Eye: Identification of Dual Molecular Diagnosis in Patients Affected by Hearing Loss. | Biomedicines | 2021 | 35052694 | PubTator, text mining | PubMed |
| Precision Medicine through Next-Generation Sequencing in Inherited Eye Diseases in a Korean Cohort. | Genes (Basel) | 2021 | 35052368 | PubTator, text mining | PubMed |
| Identification of Breast Cancer Immune Subtypes by Analyzing Bulk Tumor and Single Cell Transcriptomes. | Front Cell Dev Biol | 2021 | 35047498 | PubTator, text mining | PubMed |
| Classification of CHD7 Rare Variants in Chinese Congenital Hypogonadotropic Hypogonadism Patients and Analysis of Their Clinical Characteristics. | Front Genet | 2021 | 35047002 | PubTator, text mining | PubMed |
| A Next Generation Sequencing-Based Protocol for Screening of Variants of Concern in Autism Spectrum Disorder. | Cells | 2021 | 35011571 | PubTator, text mining | PubMed |
| The Role of Inflammation in Retinal Neurodegeneration and Degenerative Diseases. | Int J Mol Sci | 2021 | 35008812 | PubTator, text mining | PubMed |
| Editorial: Genetic Mutations Associated With Ocular Diseases. | Front Cell Dev Biol | 2021 | 35004704 | PubTator, text mining | PubMed |
| A Single-Cell Transcriptome Atlas of the Human Retinal Pigment Epithelium. | Front Cell Dev Biol | 2021 | 34977041 | PubTator, text mining | PubMed |
| CD8+ T Cell-Based Molecular Classification With Heterogeneous Immunogenomic Landscapes and Clinical Significance of Clear Cell Renal Cell Carcinoma. | Front Immunol | 2021 | 34970257 | PubTator, text mining | PubMed |
| The Current Challenges in Developing Biological and Clinical Predictors of Congenital Cytomegalovirus Infection. | Int J Mol Sci | 2021 | 34948284 | PubTator, text mining | PubMed |
| The Study of a 231 French Patient Cohort Significantly Extends the Mutational Spectrum of the Two Major Usher Genes MYO7A and USH2A. | Int J Mol Sci | 2021 | 34948090 | PubTator, text mining | PubMed |
| Synergistic Effects of Different Levels of Genomic Data for the Staging of Lung Adenocarcinoma: An Illustrative Study. | Genes (Basel) | 2021 | 34946821 | PubTator, text mining | PubMed |
| Somatic Mutational Profile of High-Grade Serous Ovarian Carcinoma and Triple-Negative Breast Carcinoma in Young and Elderly Patients: Similarities and Divergences. | Cells | 2021 | 34944094 | PubTator, text mining | PubMed |
| Potential of E3 Ubiquitin Ligases in Cancer Immunity: Opportunities and Challenges. | Cells | 2021 | 34943817 | PubTator, text mining | PubMed |
| Evaluation for Retinal Therapy for RPE65 Variation Assessed in hiPSC Retinal Pigment Epithelial Cells. | Stem Cells Int | 2021 | 34938339 | PubTator, text mining | PubMed |
| Clinical feature-related single-base substitution sequence signatures identified with an unsupervised machine learning approach. | BMC Med Genomics | 2021 | 34930241 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7399/papers?page=42